아르쿠스 바이오사이언시스, Inc.
US ˙ NYSE ˙ US03969F1093

SecurityRCUS / Arcus Biosciences, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in RCUS / Arcus Biosciences, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Arcus Biosciences, Inc. (US:RCUS) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 130,449 shares of Arcus Biosciences, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (RCUS) in the form of stock options. The firm currently holds call options representing 172,700 of underlying shares valued at $4,115,441 USD and put options representing 5,200 of underlying shares valued at $123,916 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

RCUS / Arcus Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F ARCUS BIOSCIENCES COM 03969F109 0 -130,449 -100.00 0 -100.00
2025-11-12 2025-09-30 13F ARCUS BIOSCIENCES COM 03969F109 130,449 7,622 6.21 1,774 77.58 0.0031
2025-08-14 2025-06-30 13F ARCUS BIOSCIENCES COM 03969F109 122,827 122,827 1,000 0.0022
2025-05-14 2025-03-31 13F ARCUS BIOSCIENCES COM 03969F109 0 -4,114 -100.00 0 -100.00
2025-05-14 2024-12-31 13F/A-1 ARCUS BIOSCIENCES COM 03969F109 4,114 -153,919 -97.40 61 -97.48 0.0001
2025-02-14 2024-12-31 13F ARCUS BIOSCIENCES COM 03969F109 4,114 -153,919 61 0.0002
2024-11-14 2024-09-30 13F ARCUS BIOSCIENCES COM 03969F109 158,033 134,264 564.87 2,416 567.40 0.0069
2024-08-14 2024-06-30 13F ARCUS BIOSCIENCES COM 03969F109 23,769 -51,071 -68.24 362 -74.36 0.0014
2024-05-10 2024-03-31 13F ARCUS BIOSCIENCES COM 03969F109 74,840 18,470 32.77 1,413 31.23 0.0054
2024-02-14 2023-12-31 13F ARCUS BIOSCIENCES COM 03969F109 56,370 -16,770 -22.93 1,077 -17.99 0.0028
2023-11-09 2023-09-30 13F ARCUS BIOSCIENCES COM 03969F109 73,140 -23,326 -24.18 1,313 -33.03 0.0044
2023-08-09 2023-06-30 13F ARCUS BIOSCIENCES COM 03969F109 96,466 96,466 1,959 0.0063
2023-02-09 2022-12-31 13F ARCUS BIOSCIENCES COM 03969F109 0 -5,833 -100.00 0 -100.00
2022-11-09 2022-09-30 13F ARCUS BIOSCIENCES COM 03969F109 5,833 -12,602 -68.36 153 -67.24 0.0003
2022-08-11 2022-06-30 13F ARCUS BIOSCIENCES COM 03969F109 18,435 18,435 467 0.0007
2022-02-11 2021-12-31 13F ARCUS BIOSCIENCES COM 03969F109 0 -228 -100.00 0 -100.00
2021-11-12 2021-09-30 13F ARCUS BIOSCIENCES COM 03969F109 228 228 8 0.0000
2021-08-10 2021-06-30 13F ARCUS BIOSCIENCES COM 03969F109 0 -1,108 -100.00 0 -100.00
2021-05-12 2021-03-31 13F ARCUS BIOSCIENCES COM 03969F109 1,108 845 321.29 31 342.86 0.0000
2021-02-10 2020-12-31 13F ARCUS BIOSCIENCES COM 03969F109 263 263 7 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ARCUS BIOSCIENCES COM Call 172,700 329.60 4,115 653.66 n/a n/a n/a
2025-11-12 2025-09-30 13F ARCUS BIOSCIENCES COM Call 40,200 290.29 547 557.83 n/a n/a n/a
2025-08-14 2025-06-30 13F ARCUS BIOSCIENCES COM Call 10,300 -50.24 84 -48.77 n/a n/a n/a
2025-05-14 2025-03-31 13F ARCUS BIOSCIENCES COM Call 20,700 158.75 162 36.13 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ARCUS BIOSCIENCES COM Call 8,000 -13.98 119 -16.20 n/a n/a n/a
2025-02-14 2024-12-31 13F ARCUS BIOSCIENCES COM Call 8,000 119 n/a n/a n/a
2024-11-14 2024-09-30 13F ARCUS BIOSCIENCES COM Call 9,300 -76.21 142 -76.13 n/a n/a n/a
2024-08-14 2024-06-30 13F ARCUS BIOSCIENCES COM Call 39,100 32.54 595 7.01 n/a n/a n/a
2024-05-10 2024-03-31 13F ARCUS BIOSCIENCES COM Call 29,500 12.17 557 10.76 n/a n/a n/a
2024-02-14 2023-12-31 13F ARCUS BIOSCIENCES COM Call 26,300 -70.38 502 -68.49 n/a n/a n/a
2023-11-09 2023-09-30 13F ARCUS BIOSCIENCES COM Call 88,800 165.07 1,594 134.26 n/a n/a n/a
2023-08-09 2023-06-30 13F ARCUS BIOSCIENCES COM Call 33,500 1,016.67 680 1,159.26 n/a n/a n/a
2023-05-12 2023-03-31 13F ARCUS BIOSCIENCES COM Call 3,000 -75.21 55 -78.40 n/a n/a n/a
2023-02-09 2022-12-31 13F ARCUS BIOSCIENCES COM Call 12,100 3,933.33 250 3,025.00 n/a n/a n/a
2022-11-09 2022-09-30 13F ARCUS BIOSCIENCES COM Call 300 -99.85 8 -99.84 n/a n/a n/a
2022-08-11 2022-06-30 13F ARCUS BIOSCIENCES COM Call 200,700 33,350.00 5,086 26,668.42 n/a n/a n/a
2022-05-12 2022-03-31 13F ARCUS BIOSCIENCES COM Call 600 -87.23 19 -90.00 n/a n/a n/a
2022-02-11 2021-12-31 13F ARCUS BIOSCIENCES COM Call 4,700 487.50 190 578.57 n/a n/a n/a
2021-11-12 2021-09-30 13F ARCUS BIOSCIENCES COM Call 800 14.29 28 47.37 n/a n/a n/a
2021-08-10 2021-06-30 13F ARCUS BIOSCIENCES COM Call 700 -22.22 19 -24.00 n/a n/a n/a
2021-05-12 2021-03-31 13F ARCUS BIOSCIENCES COM Call 900 -10.00 25 -3.85 n/a n/a n/a
2021-02-10 2020-12-31 13F ARCUS BIOSCIENCES COM Call 1,000 -9.09 26 36.84 n/a n/a n/a
2020-11-12 2020-09-30 13F ARCUS BIOSCIENCES COM Call 1,100 -54.17 19 -67.80 n/a n/a n/a
2020-08-13 2020-06-30 13F ARCUS BIOSCIENCES COM Call 2,400 59 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ARCUS BIOSCIENCES COM Put 5,200 -54.78 124 -21.15 n/a n/a n/a
2025-11-12 2025-09-30 13F ARCUS BIOSCIENCES COM Put 11,500 -13.53 156 44.44 n/a n/a n/a
2025-08-14 2025-06-30 13F ARCUS BIOSCIENCES COM Put 13,300 17.70 108 22.73 n/a n/a n/a
2025-05-14 2025-03-31 13F ARCUS BIOSCIENCES COM Put 11,300 841.67 89 417.65 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ARCUS BIOSCIENCES COM Put 1,200 33.33 18 30.77 n/a n/a n/a
2025-02-14 2024-12-31 13F ARCUS BIOSCIENCES COM Put 1,200 18 n/a n/a n/a
2024-11-14 2024-09-30 13F ARCUS BIOSCIENCES COM Put 900 14 n/a n/a n/a
2024-08-14 2024-06-30 13F ARCUS BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-10 2024-03-31 13F ARCUS BIOSCIENCES COM Put 5,800 -88.97 110 -89.14 n/a n/a n/a
2024-02-14 2023-12-31 13F ARCUS BIOSCIENCES COM Put 52,600 -48.28 1,005 -44.99 n/a n/a n/a
2023-11-09 2023-09-30 13F ARCUS BIOSCIENCES COM Put 101,700 -43.66 1,826 -50.20 n/a n/a n/a
2023-08-09 2023-06-30 13F ARCUS BIOSCIENCES COM Put 180,500 180,400.00 3,666 366,400.00 n/a n/a n/a
2023-05-12 2023-03-31 13F ARCUS BIOSCIENCES COM Put 100 -99.75 2 -99.88 n/a n/a n/a
2023-02-09 2022-12-31 13F ARCUS BIOSCIENCES COM Put 40,500 838 n/a n/a n/a
2022-11-09 2022-09-30 13F ARCUS BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-11 2022-06-30 13F ARCUS BIOSCIENCES COM Put 150,300 3,753.85 3,809 2,996.75 n/a n/a n/a
2022-05-12 2022-03-31 13F ARCUS BIOSCIENCES COM Put 3,900 178.57 123 115.79 n/a n/a n/a
2022-02-11 2021-12-31 13F ARCUS BIOSCIENCES COM Put 1,400 55.56 57 83.87 n/a n/a n/a
2021-11-12 2021-09-30 13F ARCUS BIOSCIENCES COM Put 900 31 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.